General Information of Drug (ID: DMUPRX2)

Drug Name
US8791257, 17 Drug Info
Synonyms CHEMBL3681194; SCHEMBL12285791; BDBM127319; US8791257, 17
Cross-matching ID
PubChem CID
68231238
TTD Drug ID
DMUPRX2

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
US8940736, 6 DMXY4SP N. A. N. A. Patented [2]
US8940736, 23 DM3PU57 N. A. N. A. Patented [2]
US8791257, 38 DMAEHCP N. A. N. A. Patented [1]
US8791257, 4 DMIQO8N N. A. N. A. Patented [1]
US8940736, 7 DM9KSVI N. A. N. A. Patented [2]
PMID22115617C2c DMX5UKA Discovery agent N.A. Investigative [3]
⏷ Show the Full List of 6 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Casein kinase II alpha prime (CSNK2A2) TTR93NU CSK22_HUMAN Inhibitor [1]

References

1 Substituted pyrrolotriazines as protein kinase inhibitors. US8791257.
2 Imidazotriazinecarbonitriles useful as kinase inhibitors. US8940736.
3 CK2alpha and CK2alpha' subunits differ in their sensitivity to 4,5,6,7-tetrabromo- and 4,5,6,7-tetraiodo-1H-benzimidazole derivatives. Eur J Med Chem. 2012 Jan;47(1):345-50.